Ventures Vii L. P. Avalon is 10% at AKESIS PHARMACEUTICALS, INC. (AKES.OB). They have made 12 open-market trades across 1 company since 2007, most recently 2008-03-25.
CIK 0001318999
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
12 open-market purchases totalling $2.1M since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKES.OB | 7,670,442 | — |
Shares reported on the most recent Form 4, priced at the 2008-03-27 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKES.OB | BUY | 2008-03-25 | 2008-03-27 | $0.85 | $2.0M | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-11-19 | 2007-11-21 | $0.73 | $15K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-09-12 | 2007-09-14 | $0.61 | $11K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-09-10 | 2007-09-12 | $0.52 | $10K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-09-06 | 2007-09-10 | $0.48 | $7K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-09-04 | 2007-09-06 | $0.47 | $12K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-30 | 2007-09-04 | $0.50 | $16K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-24 | 2007-08-28 | $0.51 | $3K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-22 | 2007-08-24 | $0.50 | $13K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-20 | 2007-08-22 | $0.52 | $34K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-16 | 2007-08-20 | $0.47 | $19K | N/A | N/A | N/A |
| AKES.OB | BUY | 2007-08-08 | 2007-08-30 | $0.48 | $7K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.